vimarsana.com
Home
Live Updates
Athenex Announces Publication of Data from Phase 3 Study Com
Athenex Announces Publication of Data from Phase 3 Study Com
Athenex Announces Publication of Data from Phase 3 Study Comparing Oral Paclitaxel Plus Encequidar Versus Intravenous Paclitaxel in Patients with Metastatic Breast Cancer in the Journal of Clinical Oncology
BUFFALO, N.Y., July 25, 2022 -- Athenex, Inc., , a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and...
Related Keywords
China ,
United States ,
Ukraine ,
American ,
Daniel Lang ,
Caileigh Dougherty ,
American Society Of Clinical Oncology Journal ,
Investor Relations Department ,
Nasdaq ,
Athenex Inc ,
Metastatic Breast ,
American Society ,
Clinical Oncology Journal ,
California San Francisco Comprehensive Cancer ,
Kuur Therapeutics ,
Nasdaq Global Market ,
Investor Relations ,